PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22005393-2	2011	Using the homology modeling of the receptors and the ligand docking simulation, here we show that these calpain inhibitors could bind to the putative N-formyl-Met-Leu-Phe (fMLF) binding site on hFPR and/or hFPRL1.	N-Formylmethionine Leucyl-Phenylalanine	150-170	formyl peptide receptor 2	Homo sapiens	206-212	
33322305-0	2020	N-Formylated Peptide Induces Increased Expression of Both Formyl Peptide Receptor 2 (Fpr2) and Toll-Like Receptor 9 (TLR9) in Schwannoma Cells-An In Vitro Model for Early Inflammatory Profiling of Schwann Cells.	N-Formylmethionine Leucyl-Phenylalanine	0-20	formyl peptide receptor 2	Homo sapiens	58-83	
21723247-3	2011	HEK-293 cells stably expressing human formyl peptide receptor (hFPR) or hFPR-like 1 (hFPRL1) displayed stimulus-specific increase in [Ca(2+)](i) in response to calpain inhibitors (PD150606, PD151746, ALLN, ALLM, MG-132, and calpeptin), gamma-secretase inhibitor I, and N-formyl-Met-Leu-Phe.	N-Formylmethionine Leucyl-Phenylalanine	269-289	formyl peptide receptor 2	Homo sapiens	85-91	
33322305-0	2020	N-Formylated Peptide Induces Increased Expression of Both Formyl Peptide Receptor 2 (Fpr2) and Toll-Like Receptor 9 (TLR9) in Schwannoma Cells-An In Vitro Model for Early Inflammatory Profiling of Schwann Cells.	N-Formylmethionine Leucyl-Phenylalanine	0-20	formyl peptide receptor 2	Homo sapiens	85-89	
33322305-5	2020	fMLF stimulation upregulated Fpr2 in RT4 cells at low concentrations (10 nM and 100 nM) but higher concentrations were required (10 microM and 50 microM) when the cells were pretreated with an activated TLR9 inhibitor.	N-Formylmethionine Leucyl-Phenylalanine	0-4	formyl peptide receptor 2	Homo sapiens	29-33